Cipher Pharmaceuticals Inc.

CPH.TOTSXHealthcare● Active

$16.85

+$0.01(+0.06%)

Market Cap$427843776

P/E Ratio—

52W High$20.56

52W Low$11.98

Avg Volume33K

Open$16.84

Beta0.48

Net Income Financials Revenue

Cipher Pharmaceuticals Inc. (CPH.TO) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CPH.TO · net income · updated Jun 8, 2026

Core profitability metrics

CPH.TO · net income · margin · TTM · CAGR

Net income was $27.8M for FY2025 (fiscal year ending 2025-12-31), up 140.9% year-over-year. Net profit margin was 54.2%. Based on available data, Cipher Pharmaceuticals Inc. has been profitable since at least 2012.

FY2025 Net Income$27.8M▲ +140.9% YoY

Trailing 12M (TTM)$31.0Mtrailing 4 quarters sum

Net Profit Margin54.2%$27.8M ÷ $51.3M

YoY Change+140.9%—

5-Year CAGR+43.6%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2012

▸ FMP /income-statement · Annual · CPH.TO net income history · CPH.TO profit margin

Annual net income data

CPH.TO · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$27.8M▲ +140.9%54.2%$51.3M

FY2024$11.5M▼ 43.4%34.6%$33.4M

FY2023$20.4M▼ 23.5%96.3%$21.2M

FY2022$26.6M▲ +243.3%128.8%$20.7M

FY2021$7.8M▲ +70.5%35.4%$21.9M

Net income vs peers (Healthcare)

CPH.TO vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Cipher Pharmaceuticals Inc.YOU

CPH.TO

$27.8M+140.9%54.2%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Cipher Pharmaceuticals Inc. (CPH.TO) reported net income of $27.8M for FY2025 (fiscal year ending 2025-12-31), up 140.9% year-over-year. The net profit margin was 54.2% — meaning the company kept $0.54 of every dollar of revenue as profit.

Based on available data, Cipher Pharmaceuticals Inc. has been profitable since at least 2012. Net income reached a peak of $27.8M in FY2025. Data available for 15 fiscal years.

Cipher Pharmaceuticals Inc.'s net profit margin was 54.2% for FY2025, based on the latest annual results.

Investors sometimes search for "Cipher Pharmaceuticals Inc. net worth" — the company's market capitalization is a separate figure from CPH.TO net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

CPH.TO net income · 5 questions

Cipher Pharmaceuticals Inc. is profitable. The company reported net income of $27.8M for FY2025, a net profit margin of 54.2%. Net income was up 140.9% year-over-year. Based on available data, Cipher Pharmaceuticals Inc. has been profitable since at least 2012.

is CPH.TO profitabledoes CPH.TO make a profitCPH.TO profitabilityCPH.TO profitable company

▸ Source: FMP /income-statement · GAAP · Cipher Pharmaceuticals Inc. · Cipher Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026